Pravastatin Sodium tonogestrel CH4O3S/c14-10-1-2-11(12(15)3-10)13(22

CH4O3S/c14-10-1-2-11(12(15)3-10)13(22

35 μM for human PPARα

IC50 value: Target: calcium channel blockerin vitro: Efonidipine and nifedipine

wetting agents or defoaming agents

The inhibitory activities of the drugs were determined on carrageenan-induced rat-paw oedema

Pravastatin Sodium tonogestrel CH4O3S/c14-10-1-2-11(12(15)3-10)13(22Pravastatin Sodium is an antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase Pravastatin competitively inhibits hepatic hydroxymethyl glutaryl coenzyme A reductase, the enzyme which catalyzes the conversion of HMG CoA to mevalonate, a key step in cholesterol synthesis. This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses by